OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

PHASE 1B OPEN‐LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH OTHER ANTICANCER AGENTS IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA (LOTIS‐7).
Published in:
Hematological Oncology, 2023, v. 41, p. 824, doi. 10.1002/hon.3166_OT07
By:
- Hess, B. T.;
- Solh, M. M.;
- Gandhi, M.;
- Wang, Y.;
- Qin, Y.;
- Yu, E.;
- Zinzani, P. L.;
- Collins, G. P
Publication type:
Article
NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826.
Published in:
Hematological Oncology, 2023, v. 41, p. 33, doi. 10.1002/hon.3163_5
By:
- Herrera, A. F.;
- LeBlanc, M.;
- Castellino, S. M.;
- Li, H.;
- Rutherford, S. C.;
- Evens, A. M.;
- Davison, K.;
- Punnett, A.;
- Hodgson, D.;
- Parsons, S. K.;
- Ahmed, S.;
- Casulo, C.;
- Bartlett, N. L.;
- Tuscano, J. M.;
- Mei, M. G.;
- Hess, B. T.;
- Jacobs, R.;
- Saeed, H.;
- Torka, P.;
- Hu, B.
Publication type:
Article
A PHASE 2 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE (LONCA) VERSUS (VS) IDELALISIB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) – LOTIS‐6.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.176_2880
By:
- Carlo‐Stella, C.;
- Depaus, J.;
- Hess, B. T.;
- Kingsley, E.;
- Zinzani, P. L.;
- Ungar, D.;
- Dai, V.;
- Wang, L.;
- Ardeshna, K. M.
Publication type:
Article